TORONTO, Sept. 4, 2018 /CNW/ - Bloom Burton Investment
Group Inc. ("BBIG") reports that on September 4, 2018, it acquired 7,083,201
preferred shares (the "Preferred Shares") of LED Medical
Diagnostics Inc. ("LED" or the "Company") through
Bloom Burton Healthcare Lending Trust. The Preferred Shares were
acquired in exchange for $3,187,440
of the Company's outstanding senior secured debentures, including
accrued interest thereon, on a dollar-for-dollar basis at a price
of $0.45 per Preferred Share (the
"Debenture Exchange").
Prior to the Debenture Exchange, BBIG did not own or control any
Preferred Shares. Immediately following the Debenture Exchange,
BBIG owned a total of 7,083,201 Preferred Shares representing
approximately 35% of the Company's issued and outstanding Preferred
Shares.
BBIG acquired the Preferred Shares for investment purposes. BBIG
may from time to time acquire additional securities, dispose of
some or all of the existing or additional securities or may
continue to hold the securities of the Company.
The Company's head office is located at Suite 810, 580 Hornby
Street, Vancouver, British
Columbia, V6C 3B6.
To obtain a copy of the early warning report filed under
applicable Canadian securities laws in connection with the
transaction hereunder, please see the Company's profile on the
SEDAR website www.sedar.com.
About Bloom Burton Investment Group Inc.
Bloom Burton Investment Group Inc. is a private asset manager
existing under the laws of Ontario.
SOURCE Bloom Burton Investment Group Inc.